Role of Tumor Necrosis Factor-Alpha in Schizophrenia and Cognitive Impairment
DOI:
https://doi.org/10.3889/oamjms.2021.6289Keywords:
Serum tumor necrosis factor-alpha levels, Cognitive, SchizophreniaAbstract
Background: Neuroinflammation and excitotoxicity play a key role as triggers and support for neurodegenerative processes, increase levels of TNF-α have been found in schizophrenic patients. Improved inflammatory processes have been demonstrated in acute and chronic schizophrenia. In schizophrenia is characterized by a collection of core symptoms that trigger individuals experiencing several cognitive disorders.
Objective: To investigate the relationship of serum TNF-α levels to impaired cognitive function in schizophrenic patients in Medan, Indonesia.
Method: This research is cross sectional analytical correlative study involving 40 male schizophrenic patients at Prof. Dr. M. Ildrem Mental Hospital through July to September 2019 that fulfilled our inclusion and exclusion criteria. Serum TNF-α levels were analyzed using Quantikine HS Human TNF-α Assay with a minimum detection limit of 0.1062 pg/ml while in the other hand, cognitive function test was carried out by using the Mini Mental State Examination.
Results: Serum TNF-α levels with a mean of 25.1216 with a standard deviation of 1.7629. There is a positive correlation with moderate correlation (r = 0.4 - <0.6) on cognitive function with the strength of correlation r = 0.434
Conclusion: We found that there is a link between serum TNF-α level and cognitive function as assessed with the Mini-Mental State Examination (MMSE).
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Urben S, Baumann P, Barcellona S, Hafil M, Preuss U, Peter- Favre C, et al. Cognitive efficacy of quetiapine in early-onset first-episode psychosis: A 12-week open label trial. Psychiatr Q. 2012;83(3):311-24. https://doi.org/10.1007/s11126-011-9201-3 PMid:22101738 DOI: https://doi.org/10.1007/s11126-011-9201-3
Riedel M, Schmitz M, Østergaard PK, Ferrannini L, Franco MA, Alfano V, et al. Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: A randomised, double-blind, crossover study (eXtRa). Schizophr Res. 2015;162(1-3):162-8. https://doi.org/10.1016/j.schres.2014.12.027 PMid:25592805 DOI: https://doi.org/10.1016/j.schres.2014.12.027
Fisekovic S, Memic A, Pasalic A. Correlation between MoCA and MMSE for the assessment of cognition in schizophrenia. Acta Inform Med. 2012;20(3):186-9. https://doi.org/10.5455/aim.2012.20.186-189 PMid:23322976 DOI: https://doi.org/10.5455/aim.2012.20.186-189
Hofer A, Fleischhacker WW. Pharmacological interventions. In: Roder V, Medalia A, editors. Neurocognition and Social Cognition in Schizophrenia Patients Basic concepts and Treatment. Switzerland: Karger; 2010. p. 145-57. https://doi.org/10.1159/isbn.978-3-8055-9339-7 DOI: https://doi.org/10.1159/isbn.978-3-8055-9339-7
Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen- Rhein M, et al. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci. 2007;257(6):360- 70. https://doi.org/10.1007/s00406-007-0739-x PMid:17629731 DOI: https://doi.org/10.1007/s00406-007-0739-x
Stahl SM. Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Application. 4th ed. New York: Cambridge University Press; 2013. p. 79-128.
Olmos G, Llado J. Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231. https://doi.org/10.1155/2014/861231 PMid:24966471 DOI: https://doi.org/10.1155/2014/861231
Ajami A, Abedian F, Hosseini SH, Akbarian E, Navaei RA, Taghipour M. Serum TNF-alpha, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Iran J Immunol. 2014;11(3):200-9. PMid:25265997
Al-Asmari A, Khan MW. Inflammation and schizophrenia: Alterations in cytokine levels and perturbation in antioxidative defense systems. Hum Exp Toxicol. 2014;33(2):115-22. https://doi.org/10.1177/0960327113493305 PMid:23836841 DOI: https://doi.org/10.1177/0960327113493305
Erguna S, Yanartas AO, Kandemira G, Yamanb A, Yildiz AM, Haklarb G, et al. The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia. Psychiatry Clin Psychopharmacol. 2018;28(1):66-72. https://doi.org/10.1080/24750573.2017.1380920 DOI: https://doi.org/10.1080/24750573.2017.1380920
Kochhann R, Maria CO, Godinho C, Camozzato A, Chaves ML. Evaluation of mini-mental state examination scores according to different age and education strata, and sex, in a large Brazilian healthy sample. Dement Neuropsychol. 2009;3(2):88-93. https://doi.org/10.1590/s1980-57642009dn30200004 PMid:29213617 DOI: https://doi.org/10.1590/S1980-57642009DN30200004
Na KS, Kim YK. Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology. 2007;56(2-3):55-63. https://doi.org/10.1159/000111535 PMid:18037815 DOI: https://doi.org/10.1159/000111535
Petrescu F, Voican SC, Silosi I. Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis. 2010;5:217-22. https://doi.org/10.2147/copd.s8330 PMid:20714375 DOI: https://doi.org/10.2147/COPD.S8330
Jiang J, See YM, Subramaniam M, Lee J. Investigation of cigarette smoking among male schizophrenia patients. PLoS One. 2013;8(8):e71343. https://doi.org/10.1371/journal.pone.0071343 PMid:23977021 DOI: https://doi.org/10.1371/journal.pone.0071343
Zhang XY, Chen DC, Xiu MH, Haile CN, Sun H, Lu L, et al. Cigarette smoking and cognitive function in Chinese male schizophrenia: A case-control study. PLoS One. 2012;7(5):e36563. https://doi.org/10.1371/journal.pone.0036563 PMid:22570726 DOI: https://doi.org/10.1371/journal.pone.0036563
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Elmeida Efffendy, Mustafa Mahmud Amin, Nurul Utami (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
